Cyclic Peptide-Metal Nanoparticle Complexes Show Antimicrobial and Anti-Cancer Properties | Research

The takeaway

Cyclic peptide complexes with copper and zinc nanoparticles demonstrated antimicrobial activity and selective anticancer effects against osteosarcoma cells.

Dual antimicrobial + anticancer
Cyclic peptide-metal nanoparticle complexes show activity against both bacteria and osteosarcoma cells

What the researchers found

Cyclic peptide cyclo-(His-Phe) chelated copper and zinc nanoparticles demonstrated antimicrobial activity and selective anticancer effects against osteosarcoma cells.

Why it matters

Osteosarcoma has limited treatment options, and metal nanoparticles are promising but toxic. Peptide carriers could enable targeted delivery, reducing side effects.

How the study worked

Synthesis of cyclic peptide-metal nanoparticle complexes with characterization of self-assembly (amyloid-type fibrils) and evaluation of antimicrobial and anticancer activity in vitro.

What this study cannot tell us

In vitro study only — no in vivo tumor model data; selectivity and safety in whole organisms untested.

How to read the evidence

In vitro laboratory study — proof-of-concept for a novel therapeutic platform, far from clinical application.

When this study was published

Published 2026 in Biomolecules.

The bigger picture

Peptide-nanoparticle conjugates represent an emerging approach for targeted cancer therapy, combining biological specificity with the potent cytotoxicity of metal nanoparticles.

Questions still open

Do these peptide-nanoparticle complexes maintain selectivity in animal tumor models?
What is the mechanism of selective osteosarcoma targeting?

Common questions

How do peptides help deliver cancer drugs?

Peptides can carry and target toxic agents (like metal nanoparticles) specifically to cancer cells, potentially reducing damage to healthy tissue compared to untargeted treatments.

What is osteosarcoma?

Osteosarcoma is the most common type of bone cancer, typically affecting children and young adults. Treatment options are limited, making new targeted approaches especially valuable.

Read the original research

Cyclo-(His-Phe) Complexes with Copper and Zinc Nanoparticles Have Antimicrobial Properties and Targeted Anticancer Potential Against Osteosarcoma Cells.

Biomolecules, 16(2)

View on PubMed ↗Publisher’s paper ↗

Citation

Apostolidou, Chrysanthi Pinelopi; Charalambidis, Georgios; Gialouri, Aikaterini; Chatzinikolaidou, Maria; Mitraki, Anna. (2026). Cyclo-(His-Phe) Complexes with Copper and Zinc Nanoparticles Have Antimicrobial Properties and Targeted Anticancer Potential Against Osteosarcoma Cells.. Biomolecules, 16(2). https://doi.org/10.3390/biom16020284